STOCK TITAN

LB Pharmaceuticals: TCG Crossover Fund II reports 2.4%

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

LB Pharmaceuticals Inc. (LBRX) ownership amendment reports a 765,050-share position, with shared voting and dispositive power reported by TCG Crossover Fund II, L.P., its general partner TCG Crossover GP II, LLC, and Chen Yu, the GP’s sole managing member. The shares are held of record by the fund. The reported stake is 2.4%, based on 32,363,040 shares outstanding as of November 3, 2026. The reporting persons disclaim group status and beneficial ownership except to the extent of their pecuniary interests.

Reported share position 765,050 shares Shared voting and dispositive power reported by each reporting person
Percent of class 2.4% Based on shares outstanding as of November 3, 2026
Shares outstanding 32,363,040 shares As of November 3, 2026, as reported by LB Pharmaceuticals Inc.
beneficial ownership regulatory
"Each Reporting Person disclaims beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared Voting Power 765,050.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 765,050.00"
pecuniary interest regulatory
"except to the extent of such Reporting Person's pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LBRX shares are reported in the ownership amendment?

The amendment reports 765,050 shares, equal to 2.4% of the class based on 32,363,040 shares outstanding as of November 3, 2026. The fund holds the shares of record, and the same position is reported by the fund, its general partner and Chen Yu.

Who may have voting and dispositive power over the LBRX shares?

TCG Crossover GP II, LLC, as general partner of TCG Crossover Fund II, L.P., may be deemed to have voting, investment and dispositive power over the shares. Chen Yu, the GP’s sole managing member, may be deemed to share those powers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





50180M108

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: These securities are held of record by TCG Crossover II (as defined in Item 2(a) below). TCG Crossover GP II (as defined in Item 2(a) below) is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 32,363,040 shares of Common Stock outstanding as of November 3, 2026, as reported by the Issuer (as defined in Item 1(a) below) in its quarterly report filed with the Securities and Exchange Commission (the Commission) on November 5, 2026 (the Form 10-Q).


SCHEDULE 13G




Comment for Type of Reporting Person: These securities are held of record by TCG Crossover II. TCG Crossover GP II is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 32,363,040 shares of Common Stock outstanding as of November 3, 2026, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G




Comment for Type of Reporting Person: These securities are held of record by TCG Crossover II. TCG Crossover GP II is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities. Based on 32,363,040 shares of Common Stock outstanding as of November 3, 2026, as reported by the Issuer in the Form 10-Q.


SCHEDULE 13G



TCG Crossover GP II, LLC
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:11/16/2026
TCG Crossover Fund II, L.P.
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, Authorized Signatory
Date:11/16/2026
Chen Yu
Signature:/s/ Craig Skaling
Name/Title:Craig Skaling, as Attorney-in-Fact for Chen Yu
Date:11/16/2026

Keep reading